Table 3.
Q1 |
Q2 |
Q3 |
Q4 |
P value for trend | |
---|---|---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
CHD |
|
|
|
|
|
Model 1* |
1 |
1.73 (1.36-2.19) |
1.95 (1.70-2.45) |
2.56 (1.95-3.89) |
<0.001 |
Model 2† |
1 |
1.71 (1.35-2.17) |
1.90 (1.63-2.42) |
2.45 (1.82-3.56) |
<0.001 |
Model 3‡ |
1 |
1.65 (1.28-2.14) |
1.82 (1.63-2.35) |
2.34 (1.73-3.45) |
<0.001 |
Stroke |
|
|
|
|
|
Model 1* |
1 |
1.40 (1.02-1.96) |
1.74 (1.29-2.43) |
2.41 (2.02-3.65) |
<0.001 |
Model 2† |
1 |
1.36 (1.03-1.93) |
1.67 (1.27-2.41) |
2.27 (1.92-3.39) |
<0.001 |
Model 3‡ |
1 |
1.30 (1.02-1.81) |
1.60 (1.23-2.29) |
2.18 (1.86-3.28) |
<0.001 |
CVD |
|
|
|
|
|
Model 1* |
1 |
1.39 (1.14-1.68) |
1.87 (1.54-2.44) |
2.50 (2.09-3.47) |
<0.001 |
Model 2† |
1 |
1.31 (1.11-1.62) |
1.77 (1.49-2.48) |
2.40 (2.06-3.40) |
<0.001 |
Model 3‡ | 1 | 1.28 (1.09-1.56) | 1.64 (1.35-2.38) | 2.16 (1.80-3.29) | <0.001 |
*Model 1 adjusted for age and gender.
†Model 2 further adjusted for alcohol drinking, smoking, education, physical activity, TC, LDL and treatments (including antihypertensive therapy, antihyperlipidemic therapy and antihyperglycemic therapy).
‡Model 3 further adjusted for metabolic syndrome and BMI.